Updated: June 13, 2026
Venture Capital Firm
Aglaia Oncology Fund
USA
Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention diagnosis and therapy.
Funding raised
$50M
About the program
Program type
Investment stage
Location
Countries invested